| |
| |
|
| Insider
Information: |
Bischofberger Norbert W |
| Relationship: |
|
| City: |
Foster City |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,830,606 |
|
|
Indirect Shares
|
7,743,294 |
|
|
| Direct
Value |
$1,284,127 |
|
|
|
Indirect Value
|
$151,839,078 |
|
|
| Total
Shares |
10,573,900 |
|
|
| Total
Value |
$153,123,205 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Gilead Sciences Inc |
GILD |
EVP, R&D and CSO |
2018-02-21 |
19,602 |
2018-02-21 |
2,317,800 |
Premium* |
|
|
Kronos Bio, Inc. |
KRON |
|
2024-02-15 |
2,811,004 |
2024-02-15 |
5,425,494 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRON |
Kronos Bio, Inc. |
PRESIDENT & CEO |
• • – |
2024-02-15 |
4 |
A |
$0.00 |
$0 |
D/D |
270,339 |
2,811,004 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-17 |
4 |
B |
$1.08 |
$106,162 |
D/D |
97,935 |
2,540,665 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-16 |
4 |
B |
$1.00 |
$261,514 |
D/D |
262,433 |
2,442,730 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2023-11-15 |
4 |
B |
$0.80 |
$1,102,718 |
D/D |
1,370,688 |
2,180,297 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-19 |
4 |
B |
$3.78 |
$1,134,510 |
D/D |
300,000 |
809,609 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-18 |
4 |
B |
$3.72 |
$768,046 |
D/D |
206,198 |
509,609 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2022-05-17 |
4 |
B |
$3.83 |
$348,529 |
D/D |
90,931 |
303,411 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2021-12-06 |
4 |
B |
$12.09 |
$173,492 |
D/D |
14,356 |
212,480 |
2.81 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-12-10 |
4 |
A |
$0.00 |
$0 |
D/D |
198,124 |
198,124 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-10-14 |
4 |
A |
$0.00 |
$2,999,992 |
I/I |
3,208,835 |
263,750 |
0 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEO |
• • – |
2020-10-14 |
4 |
B |
$19.00 |
$1,814,500 |
I/I |
95,500 |
4,370,496 |
2.66 |
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEOOfficer |
• • – |
2020-10-08 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
2,121,159 |
|
- |
|
| KRON |
Kronos Bio, Inc. |
President & CEOOfficer |
• • • |
2020-10-08 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
2,121,161 |
|
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
A |
$0.00 |
$0 |
D/D |
23,273 |
36,066 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
D |
$80.69 |
$570,559 |
D/D |
(7,071) |
28,995 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
9,393 |
19,602 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-21 |
4 |
GA |
$0.00 |
$0 |
I/I |
9,393 |
2,317,800 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2018-02-15 |
4 |
A |
$62.35 |
$21,198 |
D/D |
340 |
12,793 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-11-20 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
2,308,407 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
D |
$70.31 |
$497,092 |
D/D |
(7,070) |
24,011 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
A |
$0.00 |
$0 |
D/D |
8,794 |
31,081 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
11,558 |
2,318,407 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
11,558 |
12,453 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2017-02-15 |
4 |
A |
$59.33 |
$18,689 |
D/D |
315 |
22,287 |
0 |
- |
|
| GILD |
Gilead Sciences Inc |
EVP, R&D and CSO |
• • – |
2016-11-22 |
4 |
GD |
$0.00 |
$0 |
I/I |
10,000 |
2,306,849 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
